| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $19.7M | — |
| Gross Profit | -$714K | +2.6% |
| R&D Expense | $3.4M | +50.9% |
| SG&A Expense | $20.0M | +34.0% |
| Operating Income | -$24.1M | -25.0% |
| Pre-tax Income | -$25.9M | +10.5% |
| Income Tax | $0 | — |
| Net Income | -$25.9M | +10.5% |
| EPS (Basic) | -$548.26 | -9941.4% |
| EPS (Diluted) | -$548.26 | -9941.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.7M | +1193.6% |
| Accounts Receivable | $5.4M | +6353.0% |
| Current Assets | $23.6M | +1161.3% |
| Total Assets | $35.0M | +267.2% |
| Current Liabilities | $11.1M | +193.3% |
| Long-term Debt | $924K | — |
| Total Liabilities | $12.7M | +162.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.2M | -12.5% |
| Capital Expenditures | $6.1M | +182.8% |
| Investing Cash Flow | -$6.2M | -120.3% |
| Financing Cash Flow | $37.0M | +92.7% |
| Free Cash Flow | -$24.3M | -32.7% |
| Stockholders' Equity |
| $22.2M |
| +375.6% |